Drugs / Inactivated, Split-Virion Influenza Virus
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00524940 | Aug → Sep 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00606359 Comparator | Nov 2007 → Feb 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 2 | NCT00258934 Comparator | Sep 2005 → Jun 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated, Split-Virion Influenza Virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00524940 ↗ |
| Modality | Vaccine | “Inactivated, Split-Virion Influenza Vaccine” NCT00524940 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00524940 ↗ |